Nature's Sunshine Products Inc (NATR): Total Assets
$261.15M
As of 2025-12-31
$259.82M
As of 2026-06-30
+4.4%
3-year compound annual growth
+0.9%
5-year compound annual growth
+2.7%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $261.15M | +8.4% | 2026-03-10, Balance as of period end |
| 2024-12-31 | $240.85M | -3.6% | 2026-03-10, Balance as of period end |
| 2023-12-31 | $249.77M | +8.7% | 2025-03-11, Balance as of period end |
| 2022-12-31 | $229.78M | -11.2% | 2024-03-12, Balance as of period end |
| 2021-12-31 | $258.87M | +3.8% | 2023-03-16, Balance as of period end |
| 2020-12-31 | $249.50M | +17.1% | 2022-03-08, Balance as of period end |
| 2019-12-31 | $213.07M | +10.4% | 2021-03-10, Balance as of period end |
| 2018-12-31 | $193.02M | -1.1% | 2020-03-11, Balance as of period end |
| 2017-12-31 | $195.19M | -5.0% | 2019-03-08, Balance as of period end |
| 2016-12-31 | $205.57M | +2.5% | 2018-03-16, Balance as of period end |
| 2015-12-31 | $200.52M | +1.9% | 2017-03-14, Balance as of period end |
| 2014-12-31 | $196.80M | -1.4% | 2016-03-14, Balance as of period end |
| 2013-12-31 | $199.61M | +2.9% | 2015-03-13, Balance as of period end |
| 2012-12-31 | $193.92M | +10.3% | 2014-03-17, Balance as of period end |
| 2011-12-31 | $175.81M | +10.3% | 2013-03-07, Balance as of period end |
| 2010-12-31 | $159.41M | n/a | 2012-03-05, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $261.15M | +8.4% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $605.19M | +1.9% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | $936.02M | +1.8% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $1.17B | -1.1% |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $842.81M | +25.7% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $1.75B | +37.6% |
| Innoviva, Inc. (INVA) | 2025-12-31 | $1.64B | +25.7% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $598.73M | +20.3% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | $501.60M | +15.1% |
Compare NATR, TVTX, BBIO, ZLAB side by side · Screen every company in Pharmaceutical Preparations ↗